This is an article summary of "Real-Life Prescribing of SGLT2 Inhibitors: How to Handle the Other Medications, Including Glucose-Lowering Drugs and Diuretics" by Aisha Shaikh on behalf of coauthors.

A hyaluronan synthesis inhibitor delays progression of diabetic kidney disease in a mouse experimental model

Kidney360 is ASN's first open access, online only, general kidney journal that includes content from all disciplines of kidney science. Published content includes both clinical and basic science papers. Kidney360 promises to bring you the same high-quality peer-review you've come to expect from ASN's publications.